Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 13;2(3):ofv117.
doi: 10.1093/ofid/ofv117. eCollection 2015 Sep.

Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States

Brian H Harcourt  1 , Raydel D Anderson  1 , Henry M Wu  1 , Amanda C Cohn  1 , Jessica R MacNeil  1 , Thomas H Taylor  1 , Xin Wang  1 , Thomas A Clark  1 , Nancy E Messonnier  1 , Leonard W Mayer  1
Affiliations

Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States

Brian H Harcourt et al. Open Forum Infect Dis. .

Abstract

Background. Antimicrobial treatment and chemoprophylaxis of patients and their close contacts is critical to reduce the morbidity and mortality and prevent secondary cases of meningococcal disease. Through the 1990's, the prevalence of antimicrobial resistance to commonly used antimicrobials among Neisseria meningitidis was low in the United States. Susceptibility testing was performed to ascertain whether the proportions of isolates with reduced susceptibility to antimicrobials commonly used for N meningitidis have increased since 2004 in the United States. Methods. Antimicrobial susceptibility testing was performed by broth microdilution on 466 isolates of N meningitidis collected in 2004, 2008, 2010, and 2011 from an active, population-based surveillance system for susceptibility to ceftriaxone, ciprofloxacin, penicillin G, rifampin, and azithromycin. The molecular mechanism of reduced susceptibility was investigated for isolates with intermediate or resistant phenotypes. Results. All isolates were susceptible to ceftriaxone and azithromycin, 10.3% were penicillin G intermediate (range, 8% in 2008-16.7% in 2010), and <1% were ciprofloxacin, rifampin, or penicillin G resistant. Of the penicillin G intermediate or resistant isolates, 63% contained mutations in the penA gene associated with reduced susceptibility to penicillin G. All ciprofloxacin-resistant isolates contained mutations in the gyrA gene associated with reduced susceptibility. Conclusions. Resistance of N meningitidis to antimicrobials used for empirical treatment of meningitis in the United States has not been detected, and resistance to penicillin G and chemoprophylaxis agents remains uncommon. Therapeutic agent recommendations remain valid. Although periodic surveillance is warranted to monitor trends in susceptibility, routine clinical testing may be of little use.

Keywords: Neisseria meningitidis; broth microdilution; ciprofloxacin; penicillin G; susceptibility testing.

PubMed Disclaimer

References

    1. Rosenstein NE, Perkins BA, Stephens DS et al. . Meningococcal disease. N Engl J Med 2001; 344:1378–88. - PubMed
    1. Tunkel AR, Hartman BJ, Kaplan SL et al. . Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267–84. - PubMed
    1. American Academy of Pediatrics. Meningococcal infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 28th ed Grove Village, IL: American Academy of Pediatrics, 2012:500–9.
    1. Bilukha OO, Rosenstein N, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54:1–21. - PubMed
    1. Centers for Disease Control and Prevention (CDC). Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007–2008. MMWR Morb Mortal Wkly Rep 2008; 57:173–5. - PubMed